Cargando…

Cisplatin and radiation therapy induces an immunologic clearance of HPV-positive head and neck cancer

Detalles Bibliográficos
Autores principales:	Nowicki, PW, Spanos, WC, Lee, DW, Anderson, ME, Hoover, AJ, Lee, JH
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261718/ http://dx.doi.org/10.1186/1750-9378-4-S2-O16

Ejemplares similares

An invasion mechanism for human papillomavirus related cancers: HPV 16 E6 degrades PTPN13 allowing enhanced map kinase signaling
por: Hoover, AC, et al.
Publicado: (2009)

At the Crossroads of Molecular Biology and Immunology: Molecular Pathways for Immunological Targeting of Head and Neck Squamous Cell Carcinoma
por: Wondergem, Niels E., et al.
Publicado: (2021)

CD137 Enhancement of HPV Positive Head and Neck Squamous Cell Carcinoma Tumor Clearance
por: Lucido, Christopher T., et al.
Publicado: (2014)

Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas
por: Griso, Ana Belén, et al.
Publicado: (2022)

Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota
por: Shannon, B, et al.
Publicado: (2017)

The immunogenic radiation and new players in immunotherapy and targeted therapy for head and neck cancer
por: Sharon, Shay, et al.
Publicado: (2023)

Emerging applications for OCT in the head and neck
por: Rubinstein, Marc, et al.
Publicado: (2010)

Genotype-specific incidence and clearance rates of human papilloma virus (HPV) infection in HIV-infected women from Pune, India
por: Mane, Arati, et al.
Publicado: (2012)

Immunological Network in Head and Neck Squamous Cell Carcinoma—A Prognostic Tool Beyond HPV Status
por: Fialová, Anna, et al.
Publicado: (2020)

Our experience with optical diagnostics of the head and neck
por: Hopper, Colin, et al.
Publicado: (2010)

HPV Associated Head and Neck Cancer
por: Spence, Tara, et al.
Publicado: (2016)

Interaction of HPV16 and Cutaneous HPV in Head and Neck Cancer
por: Al-Soneidar, Walid A., et al.
Publicado: (2022)

Differential Pathlength Spectroscopy for diagnosis of head and neck cancer
por: Sterenborg, HJCM, et al.
Publicado: (2010)

c-MYC-dependent transcriptional inhibition of autophagy is implicated in cisplatin sensitivity in HPV-positive head and neck cancer
por: Medda, Alessandro, et al.
Publicado: (2023)

Medical students’ knowledge of HPV, HPV vaccine, and HPV-associated head and neck cancer
por: Du, Eric Y., et al.
Publicado: (2022)

Treatment planning for Interstitial Photodynamic Therapy for head and neck cancer
por: van Veen, RLP, et al.
Publicado: (2010)

Mechanisms of immune evasion by head and neck cancer stem cells
por: Xavier, Flávia Caló Aquino, et al.
Publicado: (2022)

Head and Neck Cancers in Developing Countries
por: Joshi, Poonam, et al.
Publicado: (2014)

Special Issue “HPV in the Head and Neck Region”
por: Dalianis, Tina, et al.
Publicado: (2021)

HPV upregulates MARCHF8 ubiquitin ligase and inhibits apoptosis by degrading the death receptors in head and neck cancer
por: Khalil, Mohamed I., et al.
Publicado: (2023)

Targeting Stress-Response Pathways and Therapeutic Resistance in Head and Neck Cancer
por: Bos, Tasia, et al.
Publicado: (2021)

IL-1/IL-1R Signaling in Head and Neck Cancer
por: Niklander, Sven E., et al.
Publicado: (2021)

Adrenergic-Angiogenic Crosstalk in Head and Neck Cancer: Mechanisms and Therapeutic Implications
por: Vincent-Chong, Vui King, et al.
Publicado: (2021)

Bmi-1: A master regulator of head and neck cancer stemness
por: Herzog, Alexandra E., et al.
Publicado: (2023)

Editorial: The state of the art in head and neck cancer and carcinogenesis translational research
por: Nör, Felipe, et al.
Publicado: (2023)

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer
por: Noronha, Vanita, et al.
Publicado: (2020)

Editorial: Immunology and Immunotherapy of Head and Neck Cancer
por: Gavrielatou, Niki, et al.
Publicado: (2021)

Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
por: Dok, Rüveyda, et al.
Publicado: (2019)

The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma
por: Zhou, Chumin, et al.
Publicado: (2020)

Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors
por: Schrank, Travis P., et al.
Publicado: (2023)

Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
por: Ferris, Robert L, et al.
Publicado: (2021)

Vasculogenic Mimicry in Head and Neck Squamous Cell Carcinoma—Time to Take Notice
por: Salem, Abdelhakim, et al.
Publicado: (2021)

HPV & head and neck cancer: a descriptive update
por: Goon, Peter KC, et al.
Publicado: (2009)

An updated overview of HPV-associated head and neck carcinomas
por: Zaravinos, Apostolos
Publicado: (2014)

Impact of HPV infection on the development of head and neck cancer
por: Betiol, J., et al.
Publicado: (2013)

Exploring the implications of HPV infection for head and neck cancer
por: Field, Nigel, et al.
Publicado: (2015)

A Review of HPV-Related Head and Neck Cancer
por: Kobayashi, Kazuhiro, et al.
Publicado: (2018)

HPV – A different view on Head and Neck Cancer
por: Wittekindt, Claus, et al.
Publicado: (2018)

DNA Methylation and HPV-Associated Head and Neck Cancer
por: Nakagawa, Takuya, et al.
Publicado: (2021)

Immunotherapy Approaches in HPV-Associated Head and Neck Cancer
por: Julian, Ricklie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1fsi0t1li08s1ehudmu2h3mjnf